Sanofi Consumer Healthcare India Ltd

BSE Code : 544250
NSE Symbol : SANOFICONR
ISIN : INE0UOS01011
Industry :PHARMACEUTICALS - MULTINATIONAL

Trade Now

Get Quotes

4,829.00 -129.40(-2.61%)

Open Price (₹)

4,852.50

Prev. Close (₹)

4,958.40

Volume (No’s)

1,125

Market Cap (₹)

11,419.50

Low Price (₹)

4,829.00

High Price (₹)

4,917.60

Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Book Closure

From Date	To Date	Announcement
05-May-2025	NA	Please find enclosed copies of newspaper publication related to notice of Annual General Meeting which will be held through VC facility on 5th May 2025, published today in Business Standard and Sakal Intimation of Second (2nd) Annual General Meeting of the Company (As Per BSE Announcement Dated on 27.03.2025) Please find enclosed Annual Report for Financial Year 2024. Shareholder Meeting - AGM on May 5, 2025 (As Per Bse Announcement Dated on 12.04.2025) Please find eclosed a summary of the proceedings of the 2nd Annual General Meeting of the Company held today i.e., 5th May 2025 at 3:30 p.m. (IST) (As Per Bse Announcement Dated on :05.05.2025)
02-May-2025	NA	Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2025 inter alia to consider and approve the Unaudited Financial Results for the Quarter ended 31st March 2025 We refer to our letter dated 25th April 2025 informing you of our Board Meeting that was scheduled today. In this regard, we wish to inform you that the Board of Directors at its meeting held today i.e., Friday, 2nd May 2025, inter-alia considered and approved the Unaudited Financial Results for the quarter ended 31st March 2025 As Per BSE Announcement Dated on 02.05.2025
29-Apr-2025	05-May-2025	Sanofi Consumer Healthcare India Limited has informed the Exchange that the Record date for the purpose of Dividend is 28th April 2025 Further to our letter dated 20th February, 2025, wherein the Board recommend a final dividend of Rs. 55 per equity share, subject to the approval by the Members at the ensuing AGM, in this regard we wish to inform you that the record date and book closure dates are as specified in the enclosed file.
25-Apr-2025	09-May-2025	Citigroup Global Markets India Pvt. Ltd. ('Manager to the Offer') has submitted to BSE a copy of Public Announcement under Regulations 3(1), 4, 5(1) and 5(2) read with Regulations 13(2)(f), 14 and 15(1) and other applicable provisions of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended for the attention of the public shareholders of Sanofi Consumer Healthcare India Ltd ('Target Company'). Source : The Fiancial Express Date : 28.10.2024 Citigroup Global Markets India Pvt. Ltd. ('Manager to the Offer') has submitted to BSE a copy of Detailed Public Statement under Regulations 3(1), 4, 5(1) and 5(2) read with Regulations 13(4), 14(3), 15(2) and other applicable provisions of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended for the attention of the Public Shareholders of Sanofi Consumer Healthcare India Ltd ('Target Company'). (As Per BSE Announcement Dated on 28.10.2024) Citigroup Global Markets India Pvt. Ltd. ('Manager to the Offer') has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Sanofi Consumer Healthcare India Ltd ('Target Company'). (As Per BSE Announcement dated on 05.11.2024) Source : The Fiancial Express Date : 11.04.2025 Newspaper Publication of Recommendations by the Committee of Independent Directors pursuant to Regulation 26(7) of the SEBI (SAST) Regulation, 2011 is enclosed. (As Per BSE Announcement Dated on 11.04.2025) Citigroup Global Markets India Pvt. Ltd. ('Manager to the Offer') has submitted to BSE a copy of Letter of Offer to the Public Shareholders of Sanofi Consumer Healthcare India Ltd ('Target Company'). (As Per Bse Announcement Dated on 16.04.2025) Source : The Fiancial Express Date : 24.04.2025 Citigroup Global Markets India Pvt. Ltd. ('Manager to the Offer') has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) and other applicable provisions of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, and subsequent amendments thereto, and corrigendum to the Detailed Public Statement and the Letter of Offer for the attention of the Shareholders of Sanofi Consumer Healthcare India Ltd ('Target Company'). (As per BSE Announcement Dated on 24/04/2025) Citigroup Global Markets India Pvt. Ltd. ('Manager to the Offer') has submitted to BSE a copy of Disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on April 29, 2025. (As Per BSE Announcement Dated on: 30/04/2025) Citigroup Global Markets India Pvt Ltd ('Manager to the Offer') has submitted to BSE a copy of Disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on April 30, 2025. (As Per BSE Announcement Dated on 02.05.2025) Citigroup Global Markets India Pvt Ltd ('Manager to the Offer') has submitted to BSE a copy of Disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on May 02, 2025. Citigroup Global Markets India Pvt Ltd ('Manager to the Offer') has submitted to BSE a copy of addendum to the Letter of Offer and Pre-Offer Advertisement and Corrigendum to the Detailed Public Statement and the Letter of Offer for the attention of the shareholders of Sanofi Consumer Healthcare India Ltd ('Target Company'). (As Per BSE Announcement Dated on 03.05.2025) Citigroup Global Markets India Pvt Ltd ('Manager to the Offer') has submitted to BSE a copy of Disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on May 05, 2025 (As per BSE Announcement Dated on 06/05/2025) Citigroup Global Markets India Pvt Ltd ('Manager to the Offer') has submitted to BSE a copy of disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on May 06, 2025. (As Per BSE Announcement Dated on 07.05.2025) Citigroup Global Markets India Pvt Ltd ('Manager to the Offer') has submitted to BSE a copy of disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on May 07, 2025. (As Per BSE Announcement Dated on :08.05.2025)
17-Apr-2025	28-Apr-2025	Sanofi Consumer Healthcare India Limited has informed the Exchange that the Record date for the purpose of Dividend is 28th April 2025. Pursuant to this letter, Members of the Company are hereby informed that, the Record Date for the purpose of payment of final dividend is now being modified from Monday, 28th April 2025 to Thursday, 17th April 2025. (As Per Bse Announcement Dated on 09.04.2025)